Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New study checks if sugar sensors work in sick newborns

NCT ID NCT06363929

Knowledge-focused Sponsor: MemorialCare Health System Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early This study
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at how accurate Dexcom G6 continuous glucose monitors are for newborns with hyperinsulinism, a condition causing low blood sugar. One baby wore the sensor on their thigh for 10 days in the NICU. Researchers compared the sensor's readings with standard blood sugar checks to see if the device could reliably detect low sugar levels.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

1 person

The number who actually took part.

Started

Jun 2023

Finished

Sep 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Neonates with hyperinsulinism in the Miller Children's Hospital Neonatal Intensive Care Unit

Ages

24 hours to 3 months

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age: 0-90 days old * Gestational Age: \> 28 weeks gestational age * Diagnosis of hyperinsulinism based on critical sample and/or glucagon challenge Exclusion Criteria: * Diffuse skin disease such that placement of a Dexcom G6 sensor would be difficult to secure * Infants colonized or infected with multi-drug resistant organisms (i.e. MRSA, VRE, ESBL producing bacteria) * Infants on hypothermic protocols * Infants expected to remain in the NICU \<24 hours * Infants enrolled in a competing clinical trial * Family/team have decided to limit or redirect from aggressive NICU technological support * Ward of the state

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hyperinsulinism are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

hyperinsulinism

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Hyperinsulinism Hypoglycemia neonatal

Contacts and locations

Locations

  • Miller Children's Hospital

    Long Beach, California, 90806, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.